Cannabis Law Report

SEPTEMBER 8, 2019

Or, in layman’s terms, the Supreme Court has essentially affirmed the legality of recreational marijuana and is simply waiting for lawmakers in the country to hash out the details. can be partially attributed to the success of GW Pharmaceuticals ( NASDAQ:GWPH ) , the cannabinoid-based drug developer that had the U.S.

Pharmaceutical 45

Pharmaceutical Recreational Patients Cannabis 45

Cannabis Law Report

NOVEMBER 24, 2021

Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Epilepsy or epilepsies were mentioned in 39% of articles. Conclusions. Palliative care indications. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

JANUARY 15, 2021

Severe and Treatment-Resistant Refractory Epilepsy. These include High CBD oil drops from Aurora, a CannEpil from MGC Pharmaceuticals, and a Tilray oral solution. Spasticity Related to Multiple Sclerosis. Vomiting and Intractable Nausea Associated With Chemotherapy. Types of Cannabinoid Therapies Allowed. Long Term Reform is Needed.

Legalization 59

Legalization Therapy Access Legislation 59

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. This is true even if the CBD comes from industrial hemp.

Law 40

Law Seed-To-Sale Hemp Recreational 40